2005
DOI: 10.1016/j.future.2004.05.014
|View full text |Cite
|
Sign up to set email alerts
|

Gene transcript clustering: a comparison of parallel approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…The PCR product was purified with a Miniprep column (QIAGEN, Valencia, CA) and then combined with PCR products generated in the same manner (but with distinct bar codes) and submitted to the University of Minnesota sequencing facility. Sequences were clustered as described previously (Scheetz et al, 2005).…”
Section: Methodsmentioning
confidence: 99%
“…The PCR product was purified with a Miniprep column (QIAGEN, Valencia, CA) and then combined with PCR products generated in the same manner (but with distinct bar codes) and submitted to the University of Minnesota sequencing facility. Sequences were clustered as described previously (Scheetz et al, 2005).…”
Section: Methodsmentioning
confidence: 99%
“…Local clustering of the ESTs was performed using the sequence-based clustering program UIcluster [82], allowing matches based on both the forward and reverse complements.…”
Section: Methodsmentioning
confidence: 99%
“…ESTprep [ 80 ] and RepeatMasker [ 81 ] programs were used to assess the presence of the following EST features: vector cloning site, restriction site, polyadenylation tail and signal sequence, library tag, and potential contaminating sequences from Escherichia coli as described in [ 78 ]. Local clustering of the ESTs was performed using the sequence-based clustering program UIcluster [ 82 ], allowing matches based on both the forward and reverse complements.…”
Section: Methodsmentioning
confidence: 99%
“…The bio-statistical analysis of the HIV-1 genotype datasets aims to identify patterns of mutations (or naturally occurring polymorphisms) associated with resistance to antiviral drugs and to predict the degree of in-vitro or in-vivo sensitivity to available drugs from an HIV-1 genetic sequence. The statistical challenges in doing such analyses arise from the high dimensionality of these data [49]. Direct application of the well-known mathematical approaches to analysis of HIV-1 genotype results in a lot of problems.…”
Section: Case 1:transmission Of Resistance In Hivmentioning
confidence: 99%